...
首页> 外文期刊>Journal of Cancer Research and Clinical Oncology >Increase of N1,N12-diacetylspermine in tissues from colorectal cancer and its liver metastasis
【24h】

Increase of N1,N12-diacetylspermine in tissues from colorectal cancer and its liver metastasis

机译:大肠癌组织中N1,N12-二乙酰基精胺的增加及其肝转移

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Purpose: N1,N12-Diacetylspermine (DiAcSpm) is a tumor marker featured by increase in the urine of patients with cancers, including early colorectal cancer, but where and how DiAcSpm is made remains unclear. We aimed to clarify whether colorectal cancer tissues produce increased amounts of DiAcSpm, and if they do, to examine whether tissue DiAcSpm level may serve as a criterion of tissue malignancy. Methods: Tissue samples were obtained from 140 patients (13 low-grade intraepithelial neoplasia, 98 high-grade intraepithelial neoplasia and 29 colorectal cancer) treated for colorectal cancer and intraepithelial neoplasia at Tokyo Metropolitan Komagome Hospital between November 2007 and April 2011. The DiAcSpm level in cancer and adjacent normal tissue extracts was compared, and its relationship with clinical stages of the diseases was analyzed. Results: DiAcSpm levels were higher in colorectal cancer tissue (p 0.01, n = 12) and its liver metastasis (p 0.05, n = 5) than in adjacent normal tissues. The tumorormal ratio of tissue DiAcSpm content was examined for endoscopically obtained tumor and adjacent normal tissues from patients with intraepithelial neoplasia. The ratio was greater than 1.5 in 38 % (5/13) and 78 % (84/108) of low-grade intraepithelial neoplasia and high-grade intraepithelial neoplasia, respectively. Conclusions: Tissue DiAcSpm levels increase in the tissue of colorectal cancer and also in precancerous lesion, such as high-grade intraepithelial neoplasia. The increase is considered a sign that a tissue is acquiring malignant characteristics. It is likely that the DiAcSpm produced by cancer cells is responsible for the frequent increase in urinary DiAcSpm in early cancer patients.
机译:目的:N1,N12-二乙酰基精胺(DiAcSpm)是一种肿瘤标志物,其特征在于癌症患者(包括早期大肠癌)的尿液增加,但DiAcSpm的制备位置和制备方法尚不清楚。我们旨在阐明结直肠癌组织是否产生增加的DiAcSpm量,并且如果这样做,则检查组织DiAcSpm的水平是否可以作为组织恶性标准。方法:从2007年11月至2011年4月在东京都驹mag医院接受治疗的140例患者(13例低度上皮内瘤样病变,98例高级别上皮内瘤样病变和29例结直肠癌)的组织样本中进行了检查。比较了癌症和癌旁正常组织中的提取物,并分析了其与疾病临床分期的关系。结果:与邻近的正常组织相比,大肠癌组织中的DiAcSpm水平更高(p <0.01,n = 12),其肝转移率更高(p <0.05,n = 5)。内窥镜检查从上皮内瘤形成患者获得的肿瘤和邻近正常组织,检查肿瘤/组织DiAcSpm含量的正常比。低度上皮内瘤变和高度上皮内瘤变的比例分别大于1.5%和38%(5/13)和78%(84/108)。结论:结直肠癌组织以及癌前病变(如高度上皮内瘤变)的组织DiAcSpm水平升高。这种增加被认为是组织正在获得恶性特征的迹象。癌细胞产生的DiAcSpm可能是导致早期癌症患者尿DiAcSpm频繁增加的原因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号